LUCD Relative Valuation
LUCD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LUCD is overvalued; if below, it's undervalued.
Historical Valuation
Lucid Diagnostics Inc (LUCD) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -2.08. The fair price of Lucid Diagnostics Inc (LUCD) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 1.06 USD , Lucid Diagnostics Inc is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：1.06
Fair
Undervalued
-2.93
PE
1Y
3Y
5Y
Trailing
Forward
-3.93
EV/EBITDA
Lucid Diagnostics Inc. (LUCD) has a current EV/EBITDA of -3.93. The 5-year average EV/EBITDA is -2.63. The thresholds are as follows: Strongly Undervalued below -7.83, Undervalued between -7.83 and -5.23, Fairly Valued between -0.04 and -5.23, Overvalued between -0.04 and 2.56, and Strongly Overvalued above 2.56. The current Forward EV/EBITDA of -3.93 falls within the Historic Trend Line -Fairly Valued range.
-3.63
EV/EBIT
Lucid Diagnostics Inc. (LUCD) has a current EV/EBIT of -3.63. The 5-year average EV/EBIT is -2.34. The thresholds are as follows: Strongly Undervalued below -7.18, Undervalued between -7.18 and -4.76, Fairly Valued between 0.08 and -4.76, Overvalued between 0.08 and 2.50, and Strongly Overvalued above 2.50. The current Forward EV/EBIT of -3.63 falls within the Historic Trend Line -Fairly Valued range.
16.41
PS
Lucid Diagnostics Inc. (LUCD) has a current PS of 16.41. The 5-year average PS is 26.59. The thresholds are as follows: Strongly Undervalued below -64.63, Undervalued between -64.63 and -19.02, Fairly Valued between 72.19 and -19.02, Overvalued between 72.19 and 117.80, and Strongly Overvalued above 117.80. The current Forward PS of 16.41 falls within the Historic Trend Line -Fairly Valued range.
-3.82
P/OCF
Lucid Diagnostics Inc. (LUCD) has a current P/OCF of -3.82. The 5-year average P/OCF is -2.93. The thresholds are as follows: Strongly Undervalued below -6.86, Undervalued between -6.86 and -4.89, Fairly Valued between -0.96 and -4.89, Overvalued between -0.96 and 1.01, and Strongly Overvalued above 1.01. The current Forward P/OCF of -3.82 falls within the Historic Trend Line -Fairly Valued range.
-3.35
P/FCF
Lucid Diagnostics Inc. (LUCD) has a current P/FCF of -3.35. The 5-year average P/FCF is -2.54. The thresholds are as follows: Strongly Undervalued below -7.53, Undervalued between -7.53 and -5.04, Fairly Valued between -0.04 and -5.04, Overvalued between -0.04 and 2.45, and Strongly Overvalued above 2.45. The current Forward P/FCF of -3.35 falls within the Historic Trend Line -Fairly Valued range.
Lucid Diagnostics Inc (LUCD) has a current Price-to-Book (P/B) ratio of -4.55. Compared to its 3-year average P/B ratio of 2.66 , the current P/B ratio is approximately -270.97% higher. Relative to its 5-year average P/B ratio of 2.18, the current P/B ratio is about -308.90% higher. Lucid Diagnostics Inc (LUCD) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -59.91%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -50.19% , the current FCF yield is about -100.00% lower.
-4.63
P/B
Median3y
2.66
Median5y
2.18
-32.41
FCF Yield
Median3y
-59.91
Median5y
-50.19
Competitors Valuation Multiple
The average P/S ratio for LUCD's competitors is 10.76, providing a benchmark for relative valuation. Lucid Diagnostics Inc Corp (LUCD) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 3.33%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of LUCD increased by 29.47% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.93 to -1.35.
The secondary factor is the Revenue Growth, contributed 3.33%to the performance.
Overall, the performance of LUCD in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Lucid Diagnostics Inc (LUCD) currently overvalued or undervalued?
What is Lucid Diagnostics Inc (LUCD) fair value?
How does LUCD's valuation metrics compare to the industry average?
What is the current P/B ratio for Lucid Diagnostics Inc (LUCD) as of Dec 05 2025?
What is the current FCF Yield for Lucid Diagnostics Inc (LUCD) as of Dec 05 2025?
What is the current Forward P/E ratio for Lucid Diagnostics Inc (LUCD) as of Dec 05 2025?